Nanology Labs Stock
Nanology Labs is a pharmaceutical company that harnesses ​advanced nanotechnology to detect and treat cancers at the early stages.
Sign up today and learn more about Nanology Labs Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Nanology Labs Stock
Nanology Labs state-of-the-art platform technology TERP enables active transportation of diagnostic and therapeutic agents/molecules to the brain tumor tissue. Blood-brain-barrier (BBB) is a formidable barrier that blocks brain entry of most of drugs and imaging agents. TERP can cross intact BBB system offering access to brain tumor tissues at early stages. ​
Funding History
| April 2019 | $0 |
|---|
Press
canadianbiomassmagazine - Mar, 3 2024
Ontario biotech start-ups get government funding boostcardinalnews - Dec, 21 2023
Cancer-fighting companies win chance to innovate in ...betakit - May, 18 2021
Today in funding: Nanology Labs, Covalent, Audioptics Medical | BetaKitEquityZen Recognized As:
